Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'CP-99,219' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 131 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Zinner, SH; Vostrov, SN; Lubenko, IY; Portnoy, YA; Cornaglia, G; Firsov, AA
      Comparative anti-staphylococcal effects of gemifloxacin and trovafloxacin in an in vitro dynamic model in terms of AUC/MIC and dose relationships

      DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
    2. Rafay, AM
      Comparative in-vitro activity of trovafloxacin and other related drugs against isolates of streptococcus oralis

      SAUDI MEDICAL JOURNAL
    3. Jonas, D; Engels, I; Friedhoff, C; Spitzmuller, B; Daschner, FD; Frank, U
      Efficacy of moxifloxacin, trovafloxacin, clinafloxacin and levofloxacin against intracellular Legionella pneumophila

      Journal of antimicrobial chemotherapy
    4. Coyle, EA; Kaatz, GW; Rybak, MJ
      Activities of newer fluoroquinolones against ciprofloxacin resistant Streptococcus pneumoniae

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    5. Stearne, LET; Gyssens, IC; Goessens, WHF; Mouton, JW; Oyen, WJG; Van der Meer, JWM; Verbrugh, HA
      In vivo efficacy of trovafloxacin against Bacteroides fragilis in mixed infection with either Escherichia coli or a vancomycin-resistant strain of Enterococcus faecium in an established-abscess murine model

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    6. Stearne, LET; Kooi, C; Goessens, WHF; Bakker-Woudenberg, IAJM; Gyssens, IC
      In vitro activity of trovafloxacin against Bacteroides fragilis in mixed culture with either Escherichia coli or a vancomycin-resistant strain of Enterococcus faecium determined by an anaerobic time-kill technique

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    7. Takahata, M; Shimakura, M; Hori, R; Kizawa, K; Todo, Y; Minami, S; Watanabe, Y; Narita, H
      In vitro and in vivo efficacies of T-3811ME (BMS-284756) against Mycoplasma pneumoniae

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    8. Kronvall, G; Holst, E
      Calibration of the disk diffusion test for trovafloxacin susceptibility testing of four anaerobic species

      CLINICAL MICROBIOLOGY AND INFECTION
    9. Clark, CL; Kelly, LM; Jacobs, MR; Appelbaum, PC
      Activity of trovafloxacin, alone and in combination with other agents, against Enterobacteriaceae by time-kill analysis

      EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
    10. Naber, KG; Hollauer, K; Kirchbauer, D; Witte, W
      In vitro activity of gatifloxacin compared with gemifloxacin, moxifloxacin, trovafloxacin, ciprofloxacin and ofloxacin against uropathogens cultured from patients with complicated urinary tract infections

      INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
    11. Brandi, L; Falconi, M; Ripa, S
      Plasmid curing effect of trovafloxacin

      FEMS MICROBIOLOGY LETTERS
    12. Ednie, LM; Credito, KL; Khantipong, M; Jacobs, MR; Appelbaum, PC
      Synergic activity, for anaerobes, of trovafloxacin with clindamycin or metronidazole: chequerboard and time-kill methods

      Journal of antimicrobial chemotherapy
    13. Ferguson, J; McEwen, J; Al-Ajmi, H; Purkins, L; Colman, PJ; Willavize, SA
      A comparison of the photosensitizing potential of trovafloxacin with that of other quinolones in healthy subjects

      Journal of antimicrobial chemotherapy
    14. Bebear, CM; Renaudin, H; Charron, A; Gruson, D; Lefrancois, M; Bebear, C
      In vitro activity of trovafloxacin compared to those of five antimicrobials against mycoplasmas including Mycoplasma hominis and Ureaplasma urealyticum fluoroquinolone-resistant isolates that have been genetically characterized

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    15. Katsarolis, I; Pefanis, A; Iliopoulos, D; Siaperas, P; Karayiannakos, P; Giamarellou, H
      Successful trovafloxacin prophylaxis against experimental streptococcal aortic valve endocarditis

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    16. Bradley, JS; Kearns, GL; Reed, MD; Capparelli, EV; Vincent, J
      Pharmacokinetics of a fluoronaphthyridone, trovafloxacin (CP 99,219), in infants and children following administration of a single intravenous dose of alatrofloxacin

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    17. Peleman, RA; Van de Velde, V; Germonpre, PR; Fleurinck, C; Rosseel, MT; Pauwels, RA
      Trovafloxacin concentrations in airway fluids of patients with severe community-acquired pneumonia

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    18. Anderson, VE; Zaniewski, RP; Kaczmarek, FS; Gootz, TD; Osheroff, N
      Action of quinolones against Staphylococcus aureus topoisomerase IV: Basisfor DNA cleavage enhancement

      BIOCHEMISTRY
    19. Hamzah, J; Skinner-Adams, T; Davis, TME
      In vitro antimalarial activity of trovafloxacin, a fourth-generation fluoroquinolone

      ACTA TROPICA
    20. Rubio, MC; Goni, P; Vergara, Y; Seral, C; Garcia, C; Gomez-Lus, P; Gomez-Lus, R
      Susceptibility of penicillin-resistant and penicillin-susceptible Streptococcus pneumoniae to newer antimicrobial agents

      JOURNAL OF CHEMOTHERAPY
    21. Alghasham, AA; Nahata, MC
      Trovafloxacin: A new fluoroquinolone

      ANNALS OF PHARMACOTHERAPY
    22. Doern, GV
      In vitro activity of selected fluoroquinolones versus Streptococcus pneumoniae

      INFECTIOUS DISEASES IN CLINICAL PRACTICE
    23. Mandell, LA
      Advances in antimicrobial therapy of community-acquired pneumonia

      CURRENT OPINION IN INFECTIOUS DISEASES
    24. Finch, RG
      A review of worldwide experience with sparfloxacin in the treatment of community-acquired pneumonia and acute bacterial exacerbations of chronic bronchitis

      INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
    25. Giamarellou-Bourboulis, EJ; Sambatakou, H; Grecka, P; Chryssouli, Z; Giamarellou, H
      Sitafloxacin (DU-6859a) and trovafloxacin: Postantibiotic effect and in vitro interactions with rifampin on methicillin-resistant Staphylococcus aureus

      DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
    26. Lacy, MK; Nicolau, DP; Banevicius, MA; Nightingale, CH; Quintiliani, R
      Protective effect of trovafloxacin, ciprofloxacin and ampicillin against Streptococcus pneumoniae in a murine sepsis model

      Journal of antimicrobial chemotherapy
    27. van Ogtrop, ML
      The antibacterial efficacy of trovafloxacin against an experimental infection with Listeria monocytogenes in hydrocortisone-treated mice

      Journal of antimicrobial chemotherapy
    28. Ng, W; Lutsar, I; Wubbel, L; Ghaffar, F; Jafri, H; McCracken, GH; Friedland, IR
      Pharmacodynamics of trovafloxacin in a mouse model of cephalosporin-resistant Streptococcus pneumoniae pneumonia

      Journal of antimicrobial chemotherapy
    29. Firsov, AA; Vasilov, RG; Vostrov, SN; Kononenko, OV; Lubenko, IY; Zinner, SH
      Prediction of the antimicrobial effects of trovafloxacin and ciprofloxacinon staphylococci using an in-vitro dynamic model

      Journal of antimicrobial chemotherapy
    30. McCormack, WM; Dalu, ZA; Martin, DH; Hook, EW; Laisi, R; Kell, P; Pluck, ND; Johnson, RB
      Double-blind comparison of trovafloxacin and doxycycline in the treatment of uncomplicated chlamydial urethritis and cervicitis

      SEXUALLY TRANSMITTED DISEASES
    31. Preheim, LC; Olsen, KM; Yue, M; Snitily, MU; Gentry, MJ
      Ethanol feeding does not affect the efficacy or pharmacokinetics of azithromycin, trovafloxacin, or ceftriaxone in a rat model of pneumococcal pneumonia

      ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH
    32. Peterson, ML; Hovde, LB; Wright, DH; Hoang, AD; Raddatz, JK; Boysen, PJ; Rotschafer, JC
      Fluoroquinolone resistance in Bacteroides fragilis following sparfloxacin exposure

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    33. Takahata, M; Mitsuyama, J; Yamashiro, Y; Yonezawa, M; Araki, H; Todo, Y; Minami, S; Watanabe, Y; Narita, H
      In vitro and in vivo antimicrobial activities of T-3811ME, a novel des-F(6)-quinolone

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    34. Davies, TA; Pankuch, GA; Dewasse, BE; Jacobs, MR; Appelbaum, PC
      In vitro development of resistance to five quinolones and amoxicillin-clavulanate in Streptococcus pneumoniae

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    35. Rodoni, D; Hanni, F; Gerber, CM; Cottagnoud, M; Neftel, K; Tauber, MG; Cottagnoud, P
      Trovafloxacin in combination with vancomycin against penicillin-resistant pneumococci in the rabbit meningitis model

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    36. Firsov, AA; Vostrov, SN; Kononenko, OV; Zinner, SH; Portnoy, YA
      Prediction of the effects of inoculum size on the antimicrobial action of trovafloxacin and ciprofloxacin against Staphylococcus aureus and Escherichia coli in an in vitro dynamic model

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    37. Entenza, JM; Vouillamoz, J; Glauser, MP; Moreillon, P
      Efficacy of trovafloxacin in treatment of experimental staphylococcal or streptococcal endocarditis

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    38. Rylander, M; Walder, M; Lind-Brandberg, L; Larsson, P; Tornqvist, E; Monsen, T; Kronvall, G
      Trovafloxacin susceptibility of aerobic clinical bacterial isolates from Sweden

      SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES
    39. Kronvall, G; Rylander, M; Walder, M; Lind-Brandberg, L; Larsson, P; Tornqvist, E; Monsen, T
      Calibration of disk diffusion antibiotic susceptibility testing: Species-related trovafloxacin interpretive zone breakpoints and selection of disk potency

      SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES
    40. Clara, LO; Biglia, MA
      Pharmacokinetics of trovafloxacin: its clinical significance.

      MEDICINA-BUENOS AIRES
    41. Niederman, MS
      Clinical contribution of the newer fluoroquinolones in acute bacterial exacerbations of chronic bronchitis.

      MEDICINA-BUENOS AIRES
    42. Provenzano, SL
      Trovafloxacin in gynecology.

      MEDICINA-BUENOS AIRES
    43. Walker, RC
      The fluoroquinolones

      MAYO CLINIC PROCEEDINGS
    44. Ling, TKW; Liu, EYM; Cheng, AFB
      In vitro activity of trovafloxacin (CP 99,219), a new fluoroquinolone against hospital isolates

      CHEMOTHERAPY
    45. GOFF DA
      DETERMINING THE COST OF ANTIMICROBIAL THERAPY - A FOCUS ON FLUOROQUINOLONES

      Formulary (Cleveland, Ohio)
    46. GIAMARELLOSBOURBOULIS EJ; SAMBATAKOU H; GRECKA P; GIAMARELLOU H
      IN-VITRO ACTIVITY OF QUINUPRISTIN DALFOPRISTIN AND NEWER QUINOLONES COMBINED WITH GENTAMICIN AGAINST RESISTANT ISOLATES OF ENTEROCOCCUS-FAECALIS AND ENTEROCOCCUS-FAECIUM/

      European journal of clinical microbiology & infectious diseases
    47. PECHERE JC; GOOTZ TD
      BACTERIOLOGICAL ACTIVITY OF TROVAFLOXACIN, A NEW QUINOLONE, AGAINST RESPIRATORY-TRACT PATHOGENS

      European journal of clinical microbiology & infectious diseases
    48. GARCIADELOMAS J; MILLAS E; LAZARO MA; BERMEJO M; GIMENO C; NAVARRO D; SANCHEZ S
      A COMPARATIVE-STUDY ON THE EFFICACY OF THE NEW QUINOLONE ALATROFLOXACIN IN THE TREATMENT OF EXPERIMENTAL LEGIONELLOSIS IN GUINEA-PIGS

      European journal of clinical microbiology & infectious diseases
    49. MELNIK G; SCHWESINGER WH; TENG R; DOGOLO LC; VINCENT J
      HEPATOBILIARY ELIMINATION OF TROVAFLOXACIN AND METABOLITES FOLLOWING SINGLE ORAL DOSES IN HEALTHY-VOLUNTEERS

      European journal of clinical microbiology & infectious diseases
    50. VINCENT J; DOGOLO L; BARIS BA; WILLAVIZE SA; TENG R
      SINGLE-DOSE AND MULTIPLE-DOSE ADMINISTRATION, DOSING REGIMENS, AND PHARMACOKINETICS OF TROVAFLOXACIN AND ALATROFLOXACIN IN HUMANS

      European journal of clinical microbiology & infectious diseases
    51. PURKINS L; OLIVER SD; WILLAVIZE SA
      AN OPEN, CONTROLLED, CROSSOVER STUDY ON THE EFFECTS OF CIMETIDINE ON THE STEADY-STATE PHARMACOKINETICS OF TROVAFLOXACIN

      European journal of clinical microbiology & infectious diseases
    52. LEOPHONTE P; BALDWIN RJT; PLUCK N
      TROVAFLOXACIN VERSUS AMOXICILLIN CLAVULANIC ACID IN THE TREATMENT OF ACUTE EXACERBATIONS OF CHRONIC OBSTRUCTIVE BRONCHITIS/

      European journal of clinical microbiology & infectious diseases
    53. ODOHERTY B; DANIEL R
      TREATMENT OF ACUTE EXACERBATIONS OF CHRONIC-BRONCHITIS - COMPARISON OF TROVAFLOXACIN AND AMOXICILLIN IN A MULTICENTER, DOUBLE-BLIND, DOUBLE-DUMMY STUDY

      European journal of clinical microbiology & infectious diseases
    54. TREMOLIERES F; DEKOCK F; PLUCK N; DANIEL R
      TROVAFLOXACIN VERSUS HIGH-DOSE AMOXICILLIN (1 G 3 TIMES DAILY) IN THETREATMENT OF COMMUNITY-ACQUIRED BACTERIAL PNEUMONIA

      European journal of clinical microbiology & infectious diseases
    55. Seifert, H
      Comparative in-vitro activities of trovafloxacin, ciproflaxacin, ofloxacin, fleroxacin and broad-spectrum beta-lactams against aerobe blood culture isolates

      ZENTRALBLATT FUR BAKTERIOLOGIE-INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY VIROLOGY PARASITOLOGY AND INFECTIOUS DISEASES
    56. ALDRIDGE KE; ASHCRAFT D; SANDERS CV
      TROVAFLOXACIN (CP-99,219), A NEW AZABICYCLO-NAPHTHYRIDONE ANTIMICROBIAL - INHIBITORY AND BACTERICIDAL ACTIVITY AGAINST CLINICAL ISOLATES OFPENICILLIN-SUSCEPTIBLE AND PENICILLIN-RESISTANT STREPTOCOCCUS-PNEUMONIAE

      Advances in therapy
    57. JONES RN; PFALLER MA; DOERN GV
      COMPARATIVE ANTIMICROBIAL ACTIVITY OF TROVAFLOXACIN TESTED AGAINST 3049 STREPTOCOCCUS-PNEUMONIAE ISOLATES FROM THE 1997-1998 RESPIRATORY-INFECTION SEASON

      Diagnostic microbiology and infectious disease
    58. DEMBRY LM; ROBERTS JC; SCHOCK KD; MARINO SP; FARREL PA; ANDRIOLE VT
      COMPARISON OF IN-VITRO ACTIVITY OF TROVAFLOXACIN AGAINST GRAM-POSITIVE AND GRAM-NEGATIVE ORGANISMS WITH QUINOLONES AND BETA-LACTAM ANTIMICROBIAL AGENTS

      Diagnostic microbiology and infectious disease
    59. VISALLI MA; BAJAKSOUZIAN S; JACOBS MR; APPELBAUM PC
      SYNERGISTIC ACTIVITY OF TROVAFLOXACIN WITH OTHER AGENTS AGAINST GRAM-POSITIVE AND GRAM-NEGATIVE ORGANISMS

      Diagnostic microbiology and infectious disease
    60. Doern, GV; Pfaller, MA; Erwin, ME; Brueggemann, AB; Jones, RN
      The prevalence of fluoroquinolone resistance among clinically significant respiratory tract isolates of Streptococcus pneumoniae in the United Statesand Canada - 1997 results from the SENTRY Antimicrobial Surveillance Program

      DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
    61. Wimer, SM; Schoonover, L; Garrison, MW
      Levofloxacin: A therapeutic review

      CLINICAL THERAPEUTICS
    62. FUCHS PC; BARRY AL; BROWN SD
      QUALITY-CONTROL LIMITS FOR DILUTION AND DISK DIFFUSION SUSCEPTIBILITYTESTS OF TROVAFLOXACIN AGAINST 8 QUALITY-CONTROL STRAINS

      Journal of clinical microbiology
    63. FISCHMAN AJ; BABICH JW; BONAB AA; ALPERT NM; VINCENT J; CALLAHAN RJ; CORREIA JA; RUBIN RH
      PHARMACOKINETICS OF [F-18] TROVAFLOXACIN IN HEALTHY-HUMAN SUBJECTS STUDIED WITH POSITRON-EMISSION-TOMOGRAPHY

      Antimicrobial agents and chemotherapy
    64. BAYER AS; LI C; ING M
      EFFICACY OF TROVAFLOXACIN, A NEW QUINOLONE ANTIBIOTIC, IN EXPERIMENTAL STAPHYLOCOCCAL ENDOCARDITIS DUE TO OXACILLIN-RESISTANT STRAINS

      Antimicrobial agents and chemotherapy
    65. PANKUCH GA; JACOBS MR; APPELBAUM PG
      POSTANTIBIOTIC EFFECT OF TROVAFLOXACIN AGAINST GRAM-POSITIVE AND GRAM-NEGATIVE ORGANISMS

      Antimicrobial agents and chemotherapy
    66. BEDOS JP; RIEUX V; BAUCHET J; MUFFATJOLY M; CARBON C; AZOULAYDUPUIS E
      EFFICACY OF TROVAFLOXACIN AGAINST PENICILLIN-SUSCEPTIBLE AND MULTIRESISTANT STRAINS OF STREPTOCOCCUS-PNEUMONIAE IN A MOUSE PNEUMONIA MODEL

      Antimicrobial agents and chemotherapy
    67. FIRSOV AA; SHEVCHENKO AA; VOSTROV SN; ZINNER SH
      INTERQUINOLONE AND INTRAQUINOLONE PREDICTORS OF ANTIMICROBIAL EFFECT IN AN IN-VITRO DYNAMIC-MODEL - NEW INSIGHT INTO A WIDELY USED CONCEPT

      Antimicrobial agents and chemotherapy
    68. KAATZ GW; SEO SM; AESCHLIMANN JR; HOULIHAN HH; MERCIER RC; RYBAK MJ
      EFFICACY OF TROVAFLOXACIN AGAINST EXPERIMENTAL STAPHYLOCOCCUS-AUREUS ENDOCARDITIS

      Antimicrobial agents and chemotherapy
    69. WISE R; JONES S; DAS I; ANDREWS JM
      PHARMACOKINETICS AND INFLAMMATORY FLUID PENETRATION OF CLINAFLOXACIN

      Antimicrobial agents and chemotherapy
    70. FIRSOV AA; VOSTROV SN; SHEVCHENKO AA; PORTNOY YA; ZINNER SH
      A NEW APPROACH TO IN-VITRO COMPARISONS OF ANTIBIOTICS IN DYNAMIC-MODELS - EQUIVALENT AREA UNDER THE CURVE MIC BREAKPOINTS AND EQUIEFFICIENTDOSES OF TROVAFLOXACIN AND CIPROFLOXACIN AGAINST BACTERIA OF SIMILAR SUSCEPTIBILITIES/

      Antimicrobial agents and chemotherapy
    71. ZINNER SH; GILBERT D; DUDLEY MN
      ACTIVITY OF TROVAFLOXACIN (WITH OR WITHOUT AMPICILLIN-SULBACTAM) AGAINST ENTEROCOCCI IN AN IN-VITRO DYNAMIC-MODEL OF INFECTION

      Antimicrobial agents and chemotherapy
    72. MONTGOMERIE JZ; SCHICK DG
      TREATMENT OF ENTEROCOCCAL PYELONEPHRITIS WITH TROVAFLOXACIN AND RIFAMPIN - IN-VITRO IN-VIVO CONTRAST

      Antimicrobial agents and chemotherapy
    73. VILSMAIER E; GOERZ T
      DIASTEREOSELECTIVE SYNTHESES OF N-PROTECTED DERIVATIVES OF A,5-ALPHA,6-BETA-6-AMINO-3-AZABICYCLO[3.1.0]HEXANE - A ROUTE TO TROVAFLOXACIN 6-BETA-DIASTEREOMER

      Synthesis
    74. MONTANARI MP; PRENNA M; MINGOIA M; RIPA S; VARALDO PE
      IN-VITRO ANTIBACTERIAL ACTIVITY OF TROVAFLOXACIN AND 5 OTHER FLUOROQUINOLONES

      Chemotherapy
    75. Weigelt, JA; Faro, S
      Antimicrobial therapy for surgical prophylaxis and for intra-abdominal andgynecologic infections

      AMERICAN JOURNAL OF SURGERY
    76. Weigelt, JA
      Overview of quinolones in the treatment and prevention of surgical infection

      AMERICAN JOURNAL OF SURGERY
    77. Vincent, J; Teng, RL; Dalvie, DK; Friedman, HL
      Pharmacokinetics and metabolism of single oral doses of trovafloxacin

      AMERICAN JOURNAL OF SURGERY
    78. Melnik, G; Schwesinger, WH; Dogolo, LC; Teng, RL; Vincent, J
      Concentrations of trovafloxacin in colonic tissue and peritoneal fluid after intravenous infusion of the prodrug alatrofloxacin in patients undergoing colorectal surgery

      AMERICAN JOURNAL OF SURGERY
    79. Martens, MG; Maccato, M; Van Hook, C; Vincent, J
      Penetration of trovafloxacin into gynecologic tissues

      AMERICAN JOURNAL OF SURGERY
    80. Vincent, J; Teng, RL; Pelletier, SM; Willavize, SA; Friedman, HL
      The bioavailability of nasogastric versus tablet-form oral trovafloxacin in healthy subjects

      AMERICAN JOURNAL OF SURGERY
    81. van Nispen, CHM; Hoepelman, AIM; Rozenberg-Arska, M; Verhoef, J; Purkins, L; Willavize, SA
      A double-blind, placebo-controlled, parallel group study of oral trovafloxacin on bowel microflora in healthy male volunteers

      AMERICAN JOURNAL OF SURGERY
    82. Vincent, J; Hunt, T; Teng, RL; Robarge, L; Willavize, SA; Friedman, HL
      The pharmacokinetic effects of coadministration of morphine and trovafloxacin in healthy subjects

      AMERICAN JOURNAL OF SURGERY
    83. Onderdonk, AB
      Pharmacodynamics and microbiology of trovafloxacin in animal models of surgical infection

      AMERICAN JOURNAL OF SURGERY
    84. Donahue, PE; Smith, DL; Yellin, AE; Mintz, SJ; Bur, F; Luke, DR
      Trovafloxacin in the treatment of intra-abdominal infections: Results of adouble blind, multicenter comparison with imipenem/cilastatin

      AMERICAN JOURNAL OF SURGERY
    85. Roy, S; Hemsell, D; Gordon, S; Godwin, D; Pearlman, M; Luke, D
      Oral trovafloxacin compared with intravenous cefoxitin in the prevention of bacterial infection after elective vaginal or abdominal hysterectomy for nonmalignant disease

      AMERICAN JOURNAL OF SURGERY
    86. Roy, S; Koltun, W; Chatwani, A; Martens, MG; Dittrich, R; Luke, DR
      Treatment of acute gynecologic infections with trovafloxacin

      AMERICAN JOURNAL OF SURGERY
    87. Williams, DJ; Hopkins, S
      Safety and tolerability of intravenous-to-oral treatment and single-dose intravenous or oral prophylaxis with trovafloxacin

      AMERICAN JOURNAL OF SURGERY
    88. NG EWM; SAMIY N; RUOFF KL; COUSINS FV; HOOPER DC; VONGUNTEN S; DAMICO DJ; BAKER AS
      TREATMENT OF EXPERIMENTAL STAPHYLOCOCCUS-EPIDERMIDIS ENDOPHTHALMITIS WITH ORAL TROVAFLOXACIN

      American journal of ophthalmology
    89. JONES RB; SCHWEBKE J; THORPE EM; DALU ZA; LEONE P; JOHNSON RB
      RANDOMIZED TRIAL OF TROVAFLOXACIN AND OFLOXACIN FOR SINGLE-DOSE THERAPY OF GONORRHEA

      The American journal of medicine
    90. GIAMARELLOSBOURBOULIS EJ; GRECKA P; GALANI I; GIAMARELLOU H
      COMPARATIVE IN-VITRO ACTIVITY AND KILLING EFFECT OF TROVAFLOXACIN, DU-6859A, LEVOFLOXACIN AND SPARFLOXACIN AGAINST STAPHYLOCOCCUS-AUREUS - FOCUS ON METHICILLIN-RESISTANT ISOLATES

      Clinical drug investigation
    91. FACINELLI B; MAGI G; PRENNA M; RIPA S; VARALDO PE
      IN-VITRO EXTRACELLULAR AND INTRACELLULAR ACTIVITY OF 2 NEWER AND 2 EARLIER FLUOROQUINOLONES AGAINST LISTERIA-MONOCYTOGENES

      European journal of clinical microbiology & infectious diseases
    92. BOROBIO MV; SUAREZ AI; RAMIREZ E; PEREA EJ
      EVALUATION OF IN-VITRO ACTIVITY OF A NEW FLUOROQUINOLONE TROVAFLOXACIN (CP-99,219) COMPARED WITH OTHER ANTIANAEROBIC ANTIMICROBIALS AGAINSTMEMBERS OF THE BACTEROIDES-FRAGILIS GROUP

      International journal of antimicrobial agents
    93. SCHICK DG; CANAWATI HN; MONTGOMERIE JZ
      IN-VITRO ACTIVITY OF THE COMBINATION OF TROVAFLOXACIN AND OTHER ANTIBIOTICS AGAINST ENTEROCOCCI

      Diagnostic microbiology and infectious disease
    94. JONES RN; BARRETT MS; DEGUCHI T
      ANTIMICROBIAL ACTIVITY OF TROVAFLOXACIN TESTED AGAINST CIPROFLOXACIN-SUSCEPTIBLE AND CIPROFLOXACIN-RESISTANT NEISSERIA-GONORRHOEAE - INTERPRETIVE CRITERIA AND COMPARISONS WITH ETEST RESULTS

      Diagnostic microbiology and infectious disease
    95. COHEN MA; HUBAND MD; GAGE JW; YODER SL; ROLAND GE; GRACHECK SJ
      IN-VITRO ACTIVITY OF CLINAFLOXACIN, TROVAFLOXACIN, AND CIPROFLOXACIN

      Journal of antimicrobial chemotherapy
    96. ANDREWS JM; HONEYBOURNE D; BRENWALD NP; BANNERJEE D; IREDALE M; CUNNINGHAM B; WISE R
      CONCENTRATIONS OF TROVAFLOXACIN IN BRONCHIAL-MUCOSA, EPITHELIAL LINING FLUID, ALVEOLAR MACROPHAGES AND SERUM AFTER ADMINISTRATION OF SINGLEOR MULTIPLE ORAL DOSES TO PATIENTS UNDERGOING FIBEROPTIC BRONCHOSCOPY

      Journal of antimicrobial chemotherapy
    97. BRIGHTY KE; GOOTZ TD
      THE CHEMISTRY AND BIOLOGICAL PROFILE OF TROVAFLOXACIN

      Journal of antimicrobial chemotherapy
    98. ROLSTON KVI; HO DH; LEBLANC B; STREETER H; DVORAK T
      IN-VITRO ACTIVITY OF TROVAFLOXACIN AGAINST CLINICAL BACTERIAL ISOLATES FROM PATIENTS WITH CANCER

      Journal of antimicrobial chemotherapy
    99. SPANGLER SK; JACOBS MR; APPELBAUM PC
      TIME-KILL STUDY OF THE ACTIVITY OF TROVAFLOXACIN COMPARED WITH CIPROFLOXACIN, SPARFLOXACIN, METRONIDAZOLE, CEFOXITIN, PIPERACILLIN AND PIPERACILLIN TAZOBACTAM AGAINST 6 ANAEROBES/

      Journal of antimicrobial chemotherapy
    100. CUNHA BA; QADRI SMH; UENO Y; WALTERS EA; DOMENICO P
      ANTIBACTERIAL ACTIVITY OF TROVAFLOXACIN AGAINST NOSOCOMIAL GRAM-POSITIVE AND GRAM-NEGATIVE ISOLATES

      Journal of antimicrobial chemotherapy


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 25/10/20 alle ore 18:38:56